{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H7",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Drug",
            "via": [
              "Immunomodulation"
            ],
            "to": "Generalised pustular psoriasis",
            "success_criteria": "形成至少2条不同作用机制的路径以增强证据基础",
            "assignee": "Proponent"
          }
        ]
      },
      {
        "hypothesis_id": "H8",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Drug",
            "via": [
              "Th17 pathway"
            ],
            "to": "Generalised pustular psoriasis",
            "success_criteria": "形成对IL-23靶向疗法的更清晰路径以巩固论证",
            "assignee": "Proponent"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ciclosporin",
          "type": "Drug",
          "label": "Ciclosporin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_tildrakizumab",
          "type": "Drug",
          "label": "Tildrakizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_brodalumab",
          "type": "Drug",
          "label": "Brodalumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_guselkumab",
          "type": "Drug",
          "label": "Guselkumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_risankizumab",
          "type": "Drug",
          "label": "Risankizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_gp_psoriasis",
          "type": "Disease",
          "label": "Generalised pustular psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_th17_pathway",
          "type": "Pathway",
          "label": "Th17 pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_immunomodulation",
          "type": "Pathway",
          "label": "Immunomodulation pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_inflammation",
          "type": "Phenotype",
          "label": "Inflammation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_skin_flare",
          "type": "Phenotype",
          "label": "Skin Flare",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Acitretin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Ciclosporin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_ciclosporin",
          "type": "Drug",
          "label": "Ciclosporin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Secukinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Etanercept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Tildrakizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_tildrakizumab",
          "type": "Drug",
          "label": "Tildrakizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Apremilast",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Brodalumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_brodalumab",
          "type": "Drug",
          "label": "Brodalumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Guselkumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_guselkumab",
          "type": "Drug",
          "label": "Guselkumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Risankizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_risankizumab",
          "type": "Drug",
          "label": "Risankizumab",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "n_acitretin",
          "target": "n_th17_pathway",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知促发Th17细胞网络"
        },
        {
          "source": "n_ciclosporin",
          "target": "n_immunomodulation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "免疫调节作用支持"
        },
        {
          "source": "n_methotrexate",
          "target": "n_immunomodulation",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通过免疫抑制改善病症"
        },
        {
          "source": "n_ustekinumab",
          "target": "n_th17_pathway",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "靶向IL-23，干预Th17反应"
        },
        {
          "source": "n_secukinumab",
          "target": "n_th17_pathway",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "直接抑制IL-17"
        },
        {
          "source": "n_infliximab",
          "target": "n_immunomodulation",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "TNF-α抑制剂，对应炎症"
        },
        {
          "source": "n_etanercept",
          "target": "n_immunomodulation",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "也为TNF-α抑制剂"
        },
        {
          "source": "n_tildrakizumab",
          "target": "n_th17_pathway",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "靶向IL-23，减轻症状"
        },
        {
          "source": "n_apremilast",
          "target": "n_immunomodulation",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "磷酸二酯酶4抑制剂，有助于控制炎症"
        },
        {
          "source": "n_brodalumab",
          "target": "n_th17_pathway",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "靶向IL-17的单抗及其作用机制"
        },
        {
          "source": "n_guselkumab",
          "target": "n_th17_pathway",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "靶向IL-23相关机制"
        },
        {
          "source": "n_risankizumab",
          "target": "n_th17_pathway",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "针对IL-23的作用"
        },
        {
          "source": "n_th17_pathway",
          "target": "n_inflammation",
          "relation": "involved_in",
          "weight": 0.87,
          "agent": "Proponent",
          "rationale": "与炎症表型直接相关"
        },
        {
          "source": "n_inflammation",
          "target": "n_gp_psoriasis",
          "relation": "associated_with",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "炎症与广泛性脓疱型银屑病直接相关"
        },
        {
          "source": "n_immunomodulation",
          "target": "n_skin_flare",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "调节免疫反应对皮肤反应影响"
        },
        {
          "source": "n_skin_flare",
          "target": "n_gp_psoriasis",
          "relation": "associated_with",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "皮肤反应与疾病的临床表现一致"
        }
      ],
      "round_index": 2
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "hypothesis_id": "H7",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "add_nodes": [
            {
              "id": "n_immunomodulation_pathway",
              "type": "Pathway",
              "label": "Immunomodulation Pathway",
              "attrs": {
                "agent": "Proponent"
              }
            }
          ],
          "add_edges": [
            {
              "source": "n_acitretin",
              "target": "n_immunomodulation_pathway",
              "relation": "acts_on",
              "weight": 0.8,
              "agent": "Proponent",
              "rationale": "药物对免疫调节通路的作用"
            },
            {
              "source": "n_immunomodulation_pathway",
              "target": "n_gp_psoriasis",
              "relation": "supports",
              "weight": 0.85,
              "agent": "Proponent",
              "rationale": "通过免疫调节影响广泛性脓疱型银屑病"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "已连接 Acitretin → Immunomodulation Pathway → Generalised pustular psoriasis，形成有效机制链"
      }
    ],
    "unexecuted_actions": [],
    "residual_gaps": [],
    "next_focus_for_pi": []
  }
}